feed,title,long_url,short_url
Benzinga,"ObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 Trials Evaluating Linzagolix in Women with Uterine Fibroids",https://www.benzinga.com/pressreleases/20/06/g16422335/obseva-sa-to-hold-conference-call-monday-july-6-to-discuss-results-from-phase-3-primrose-1-and-pri,https://j.mp/2AbxBDe
